Imperial Valley News Center
DEA Arrests Eight Defendants Linked to Coachella Valley-Based Drug Ring that Trafficked in Large Quantities of Methamphetamine
- Details
- Written by IVN
Riverside, California - Federal authorities this morning concluded a 2½-year wiretap investigation into a drug trafficking organization based in the Coachella Valley by arresting eight defendants linked to the distribution of wholesale quantities of methamphetamine.
President Of Pinnacle Workforce Solutions Sentenced To Prison
- Details
- Written by IVN
San Jose, California - John McEwan was sentenced Tuesday to over five years in prison, announced Acting United States Attorney Alex G. Tse and Federal Bureau of Investigation (FBI) Special Agent in Charge John F. Bennett.
Former Fresno-Area Auto Dealer Facing Federal Charges of Bank Fraud and Aggravated Identity Theft
- Details
- Written by FBI
Fresno, California - Scott Radtke, 56, of Clovis, was arraigned Monday on a nine-count indictment charging him with bank fraud and aggravated identity theft, U.S. Attorney McGregor W. Scott announced.
Metformin Alone or Combined with Insulin Does Not Improve or Preserve Beta-Cell Function in Youth with Impaired Glucose Tolerance or Newly Diagnosed Type 2 Diabetes
- Details
- Written by IVN
Orlando, Florida - According to recent research, the insulin resistance and pancreatic beta-cell (β-cell) dysfunction associated with type 2 diabetes (T2D) was unresponsive to treatment with metformin alone or metformin combined with insulin glargine in youth with impaired glucose tolerance (IGT), which is an element of prediabetes, or early T2D. Additionally, youth with IGT and T2D, compared to adults, are more insulin resistant, and thus their insulin is less effective in lowering blood glucose levels in their bodies. These findings from the Restoring Insulin Secretion (RISE) program’s Pediatric Medication Study were presented at the American Diabetes Association’s® (ADA’s) 78th Scientific Sessions® at the Orange County Convention Center.
Expanded Access to Prevention Programs and Acknowledging Increased Risk of Depression Among People with Diabetes
- Details
- Written by American Diabetes Association
Orlando, Florida - Diabetes is a unique and complex disease affecting more than 30 million Americans, and the individual living with diabetes is solely responsible for daily diabetes management. The added stress of this responsibility significantly increases their risk for depression and anxiety. Research has indicated that symptoms of depression have been shown to be associated with worsened blood glucose levels and increased diabetes-related complications. Therefore, diabetes prevention programs and increased awareness, screening and care for the mental health aspects of diabetes are key components in improving the quality of life for people with prediabetes (more than 84 million have prediabetes) and diabetes.
Alirocumab and Statins Highly Effective in People with Diabetes with Acute Coronary Syndrome
- Details
- Written by ADA
Orlando, Florida - People with diabetes who have experienced recent acute coronary syndrome (ACS) and take a combination of alirocumab and statins may reduce their risk of future cardiac events by more than double that of people on the same medication regimen who have similar cardiac histories, but have prediabetes or normal blood glucose levels, according to the study, “Alirocumab and Cardiovascular Outcomes in Patients with Acute Coronary Syndrome (ACS) and Diabetes - Prespecified Analyses of ODYSSEY OUTCOMES,” presented at the American Diabetes Association’s® (ADA’s) 78th Scientific Sessions® at the Orange County Convention Center.
Page 1194 of 3785